Letter to the editor on “efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis: A randomized double-blind placebo-controlled trial”

ElsevierVolume 107, March 2026, 106969Multiple Sclerosis and Related DisordersAuthor links open overlay panelSina Pakkhesal a 1, Sarvin Sanaie b 2, Amirreza Naseri c 3Show moreAccess through your organization

Check access to the full text by signing in through your organization.

Access through your organizationSection snippetsRole of funding source

None.

CRediT authorship contribution statement

Sina Pakkhesal: Investigation, Writing – original draft. Sarvin Sanaie: Conceptualization, Investigation, Writing – review & editing, Supervision. Amirreza Naseri: Conceptualization, Investigation, Supervision, Writing – original draft, Writing – review & editing.

Declaration of competing interest

The authors declare no conflicts of interest.

References (10)

There are more references available in the full text version of this article.

1

Sina Pakkhesal: Scopus ID: 57575200700

2

Sarvin Sanaie: Scopus ID: 23052644000

3

Amirreza Naseri: Scopus ID: 57217220944

View full text

© 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Comments (0)

No login
gif